These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15105310)

  • 1. Indian Medical Association wants off-label prescribing.
    Mudur G
    BMJ; 2004 Apr; 328(7446):974. PubMed ID: 15105310
    [No Abstract]   [Full Text] [Related]  

  • 2. Off-label prescribing. Legal implications.
    Henry V
    J Leg Med; 1999 Sep; 20(3):365-83. PubMed ID: 10530051
    [No Abstract]   [Full Text] [Related]  

  • 3. Off licence and off label prescribing in children: litigation fears for physicians.
    Hill P
    Arch Dis Child; 2005 Feb; 90 Suppl 1(Suppl 1):i17-8. PubMed ID: 15665151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indian experts protest against off-label drug use.
    Sharma DC
    Lancet; 2004 Apr; 363(9418):1372. PubMed ID: 15112705
    [No Abstract]   [Full Text] [Related]  

  • 5. Off-label drug use.
    Dooley AG
    Med Health R I; 2007 Feb; 90(2):63-5. PubMed ID: 17500258
    [No Abstract]   [Full Text] [Related]  

  • 6. Unlicensed and off-label drug use in children: implications for safety.
    Choonara I
    Expert Opin Drug Saf; 2004 Mar; 3(2):81-3. PubMed ID: 15006712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unlicensed and off-label drug use in children.
    Bavdekar SB; Gogtay NJ
    J Postgrad Med; 2005; 51(4):249-52. PubMed ID: 16388164
    [No Abstract]   [Full Text] [Related]  

  • 8. Pros and cons of off-label promotion investigations and prosecutions.
    Loucks MK
    Food Drug Law J; 2006; 61(3):577-83. PubMed ID: 16989041
    [No Abstract]   [Full Text] [Related]  

  • 9. Off-label and unlicensed prescribing for children: have we made any progress?
    Waller DG
    Br J Clin Pharmacol; 2007 Jul; 64(1):1-2. PubMed ID: 17577389
    [No Abstract]   [Full Text] [Related]  

  • 10. Off-label or off-limits?
    Ratner M; Gura T
    Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236
    [No Abstract]   [Full Text] [Related]  

  • 11. Shifting terrain in the regulation of off-label promotion of pharmaceuticals.
    Mello MM; Studdert DM; Brennan TA
    N Engl J Med; 2009 Apr; 360(15):1557-66. PubMed ID: 19357413
    [No Abstract]   [Full Text] [Related]  

  • 12. Compounded medicines and 'off label' prescribing - a case for more guidance.
    Fois RA; Mewes BT; McLachlan AJ; Ramzan I
    Aust Fam Physician; 2009; 38(1-2):16-20. PubMed ID: 19283230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of Food and Drug Administration--approved medications for unlabeled (off-label) uses. The legal and ethical implications.
    Torres A
    Arch Dermatol; 1994 Jan; 130(1):32-6. PubMed ID: 8285737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Off-label use and the 'explanation'].
    Kamphuis A; de Groot SJ
    Tijdschr Diergeneeskd; 2003 May; 128(10):340-1. PubMed ID: 12793041
    [No Abstract]   [Full Text] [Related]  

  • 15. Finance issue brief: mandated benefits: off-label drug coverage requirements: year end report-2003.
    Plaza CI
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-9. PubMed ID: 14870745
    [No Abstract]   [Full Text] [Related]  

  • 16. Health insurance oversight issue brief: mandated benefits: off-label drug coverage requirements: year end report--2004.
    Plaza CI
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-9. PubMed ID: 15726733
    [No Abstract]   [Full Text] [Related]  

  • 17. Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics.
    Novak E; Allen PJ
    Pediatr Nurs; 2007; 33(1):64-70. PubMed ID: 17411005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA, off-label use, and informed consent: debunking myths and misconceptions.
    Beck JM; Azari ED
    Food Drug Law J; 1998; 53(1):71-104. PubMed ID: 11795338
    [No Abstract]   [Full Text] [Related]  

  • 19. [Editorial comment on Krege S. et al: off-label use: an unsolved problem].
    Ludwig WD
    Aktuelle Urol; 2007 Jul; 38(4):299-300. PubMed ID: 17647166
    [No Abstract]   [Full Text] [Related]  

  • 20. Informed consent in off-label use and incapacitated persons.
    Elger CE; Hoppe C
    Epilepsia; 2009 Dec; 50 Suppl 12():79-80. PubMed ID: 19941536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.